Thursday, December 29, 2022

Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen

The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”

from NYT > Top Stories https://ift.tt/jYOPTCi
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Brigitte Macron’s Slur Against Feminist Protesters Prompts an Outcry in France

Brigitte Macron used a slur to criticize protesters who had interrupted a show by a French comedian accused of rape in 2021, in a case that ...